Glatiramer Completed Phase 4 Trials for Multiple Sclerosis Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00239993A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®